Hepatitis inequalities study for patients with viral markers
Part of Digestive system, Infections clinical trials.
This trial looks at differences in hepatitis care based on factors like ethnicity and income. Researchers will review existing medical records to understand who gets tested and treated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a positive test for hepatitis B or C (such as HBeAg, HBsAg, HBV DNA, or HCV RNA) or a specific diagnosis code related to liver disease or its complications.
- Your hospital records from January 2000 to March 2024 show these results or codes.
- You must have your age, gender, ethnicity, and socioeconomic status recorded (not missing).
- You should not have a serious illness or cancer that gives you less than a year to live.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how patients with chronic hepatitis B are managed when they visit non-liver clinics. It aims to improve care and may also include a survey about quality of life for those starting treatment.
This study collects a small sample of liver cells to understand how hepatitis B virus behaves in the liver and how the immune system responds. This could help improve future treatments for chronic hepatitis B.
This trial studies what happens to people with hepatitis B who have hepatitis B surface antigen for more than 6 months, are “HBeAg-negative,” and have certain blood and liver-scarring levels despite normal or near-normal liver inflammation. It may help doctors understand the best care for this specific group before clear treatment phases.
This study looks at genetic factors that may help people with chronic hepatitis B achieve a clinical cure when treated with long-acting interferon. It aims to find out why some patients respond better than others.
This study looks at the genes of people with chronic hepatitis B (HBV) to find why some people's immune cells (B cells and NK cells) stop working properly. The goal is to discover new ways to treat the disease.
This study looks at women with chronic hepatitis B or C to understand their current health status. It may help researchers find better ways to support patients like you.
Hear when a new Chronic Hepatitis B trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.